SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending following a published paper highlighting its APU's comparable performance to NVIDIA GPUs with significantly lower energy consumption, sparking community discussion around potential buyouts and market disruption.  The community is focused on the energy efficiency of GSIT's technology and its potential impact on the AI and data center sectors. Some traders are speculating about a short squeeze and further upward momentum.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem ($VSTM) is trending due to positive clinical data from a partner's lung cancer drug trial in China, demonstrating promising response rates. The community is actively discussing the implications of these results, comparing them to competitors and speculating on potential short squeezes. Despite optimism, concerns about cash position, past volatility, and management's history temper enthusiasm among some investors.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending as Bitcoin flirts with all-time highs, driving community excitement and discussions around potential breakouts. Traders are actively watching key resistance levels and analyzing potential breakouts, while also speculating about the impact of potential government shutdowns on crypto. Bullish sentiment is fueled by the possibility of new all-time highs and expectations of substantial gains.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv is trending as investors discuss its pivotal role in AI infrastructure, particularly its synergy with Nvidia and Tecogen, driving optimism about future growth. Community members highlight Vertiv's AI-driven 800 VDC power systems and cooling innovations as key to supporting power-hungry AI data centers. Investors are also monitoring upcoming earnings and potential inclusion in the S&P 500.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies ($DUOT) is trending due to growing excitement around its AI-driven solutions for data centers and gas turbine infrastructure. Community members are discussing the company's potential in hot market segments and its undervalued status, with some suggesting the company hasn't effectively communicated its full story. Positive catalysts, including rising earnings, recurring revenue, and Class I contracts, are also fueling interest.

Tecogen, Inc. engages in the production of commercial and industrial, natural-gas-fueled engine-driven, and combined heat and power (CHP) products. It operates through the Products, Services, and Energy Production segments. The Products segment designs, manufactures, and retails industrial and commercial cogeneration systems. The Services segment installs and maintains the cogeneration systems. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to customers under long-term sales agreements. The company was founded by George N. Hatsopoulos and John N. Hatsopoulos in 1987 and is headquartered in North Billerica, MA.

Tecogen Inc

Tecogen ($TGEN) is trending due to its potential synergy with Vertiv ($VRT) in providing cooling solutions for AI data centers, as highlighted in a recent article. Investors are speculating that integrating Tecogen's natural gas chillers into data centers could ease the strain on electrical grids, offering a sustainable solution for power-hungry AI operations and freeing up electrical load for GPUs.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors react to news of the company potentially expanding into rare earth mineral extraction, despite mixed earnings reports. The community is weighing the potential of this strategic shift and its implications for the company's future, with some expressing skepticism about execution and others seeing it as a game-changer. Discussions also involve a potential MOU with a global steel producer and speculation about a possible acquisition.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community debates recent price action and potential market manipulation, with some expressing frustration over its inability to sustain gains. Discussions include speculation on upcoming catalysts and technical analysis, while others point to concerns over the influence of large investment firms. Overall, sentiment seems mixed with a focus on identifying the next key price levels.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the Commercial Engines & Services and Defense & Propulsion Technologies segments. The Commercial Engines & Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense & Propulsion Technologies segment offers defense engines and critical aircraft systems. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospace is trending as investors digest Q2 earnings and raised guidance, with community members closely watching for a breakout. While some express enthusiasm for the aerospace sector, others point to a potential engine issue in a recent Air India Boeing crash affecting the stock. Overall, the community focuses on GE's long-term growth potential in commercial and defense sectors amid increased global defense spending.

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

ORBS (Eightco Holdings Inc) is trending amid discussions about its connection to Worldcoin ($WLD) and the company's strategy involving digital identity and AI authentication. Community members are actively debating the potential impact of a recent $270 million PIPE financing and the upcoming release of restricted shares, with some expressing concerns about dilution. The stock's volatility and future prospects are also key talking points, particularly in relation to its ambitious goals in the evolving landscape of AI and cryptocurrency.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Janux Therapeutics (JANX) Surges 6.8%: Is This an Indication of Further Gains?

Janux Therapeutics (JANX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Stoke Therapeutics (STOK) Surges 11.7%: Is This an Indication of Further Gains?

Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor...

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Janux Therapeutics Announces Proposed Public Offering

<a href="https://stocktwits.com/symbol/JANX">Shares of Janux Therapeutics</a> Inc. surged over 54% on Tuesday afternoon, reaching levels not seen since May and breaking a five-day losing streak.&nbsp;The rally followed the company’s Monday announcement of promising Phase I trial data for its prostate cancer treatment, JANX007.In the trial, all 16 heavily pre-treated patients demonstrated a reduction of at least 50% in prostate-specific antigen (PSA) levels, a key indicator of cancer.&nbsp;The news sparked a wave of bullish analyst notes and retail investor enthusiasm.Stifel raised its price target to $115 from $70, citing increased probabilities of success for JANX007 in second- and third-line metastatic castration-resistant prostate cancer.&nbsp;The brokerage now forecasts $1.7 billion in risk-adjusted sales from these indications.&nbsp;Leerink boosted its price target to $91, highlighting the treatment’s “best-in-class” safety and efficacy profile.Cantor Fitzgerald took an even more optimistic stance, doubling its price target to $200. The brokerage praised JANX007 for achieving “unprecedented” PSA50 and PSA90 response rates while maintaining a tolerable safety profile.&nbsp;H.C. Wainwright also raised its target, albeit more modestly, to $70, increasing its probability of launch for JANX007 to 26% from 20%.<figure class="image"><a href="https://stocktwits.com/symbol/JANX"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/JANX_sentiment_and_message_volume_on_Dec_3_f914cb43e0.png" alt="JANX sentiment and message volume on Dec 3.png" width="1318" height="318"></a><figcaption>JANX sentiment and message volume on Dec 3 as of 2:15 pm ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned ‘extremely bullish’ amid a sharp increase in message volume, with many users seeing the breakthrough as a major milestone.&nbsp;The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.Janux has selected two once-weekly dose regimens for expansion trials targeting patients with two or three prior lines of therapy.&nbsp;The stock, up 460% year-to-date, is reportedly on track for its best year ever.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/gm-stock-dips-after-plan-to-sell-battery-plant-stake/cJ9NCvaRhn">GM Stock Suffers Despite Battery Plant Stake Sale Plan: Retail Sentiment Dips To 5-Month Low</a>

Janux's stock, up 460% year-to-date, is reportedly on track for its best year ever.

Janux Therapeutics Stock Hits 7-Month High On Prostate Cancer Drug Trial Data: Retail Confidence Spikes

The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.

Equity

The treatment, a tumor-activated T-cell engager, leverages the immune system by recruiting white blood cells to attack cancer cells.


Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Navigating 5 Analyst Ratings For Janux Therapeutics

Latest Ratings for JANX
 DateFirmActionFromTo Jul 2021B of A SecuritiesInitiates Coverage OnBuy Jul 2021Cowen & Co.Initiates Coverage OnOutperform Jul 2021HC Wainwright & Co.Initiates Coverage OnBuy...

Analyst Expectations For Janux Therapeutics's Future

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.

Janux Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$26.91
Prev Close	$26.76
Open	$27.10
Dividend Yield	0.00%
50-Day Moving Average	$24.24
Beta	1.48
Avg. Volume	741,838.48
PE Ratio	-14.98

52-Week High	$71.71
52-Week Low	$21.73
Market Capitalization	$1.62B
EPS (Annual)	-$1.28
Price to Book	1.61
Revenue Per Employee	$130,716.05
Enterprise Value/EBITDA	N/A

JANX
Janux Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest JANX News

JANXJanux Therapeutics Inc